nerve stimulation
The digital MSK company is looking to bundle the non-invasive, non-addictive pain reduction device alongside the rest of its employer-focused offerings.
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
The company's implanted product acts as a closed-loop system that monitors and responds to brain activity by automatically delivering stimulation prior to the start of a seizure.
Also: Meru inks commercial agreement with dacadoo and UCSF teams up with Proscia.
The IB-Stim device adheres behind the patient's ear for up to five days, and may assist with pain reduction for up to three consecutive weeks.
The company is looking to further develop the technology for chronic disease management.